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Sampling of the lower airways of the adult cystic fibrosis (CF) lung has received insufficient detailed
consideration, with the importance of sampling strategies for bacteriological outcome not known. Although
spontaneously expectorated sputum (SES) samples are often used for diagnostic bacteriological analysis,
induced sputum (IS) methods have advantages. This study examined whether significant differences in bac-
terial content were detected when using a culture-independent, molecular profiling technique to analyze SES
or IS samples. Moreover, this work examined what trends relating to bacterial species distributions and
reproducibility were found in sequentially induced sputum samples and what implications this has for
pathogen detection. Terminal restriction fragment length polymorphism (T-RFLP) analysis was performed on
a SES sample and 4 subsequent IS samples taken at 5-min intervals from 10 clinically stable, adult CF
patients. This was repeated over 3 sampling days, with variability between samples, induction periods, and
sampling days determined. A diverse range of bacterial species, including potentially novel pathogens, was
found. No significant difference in bacterial content was observed for either SES or serial IS samples. On
average, the analysis of a single sample from any time point resolved58% of total bacterial diversity achieved
by analysis of an SES sample and 4 subsequent IS samples. The reliance on analysis of a single respiratory
sample was not sufficient for the detection of recognized CF pathogens in all instances. Close correlation
between T-RFLP and microbiological data in the detection of key species indicates the importance of these
findings in routine diagnostics for the detection of recognized and novel CF pathogens.
The selection of appropriate treatment for cystic fibrosis
(CF) airway infections, as in other diagnostic microbiological
scenarios, requires knowledge of what bacterial species are
present in a sample (3). However, for this to provide informa-
tion of clinical use, it is essential that the material analyzed
reflect the composition of secretions in the lower airways and
that this material be collected in a reproducible manner. If this
is not the case, bias is introduced (9, 11, 20).
Culture-based diagnostic microbiology has traditionally fo-
cused on the detection of a small number of species considered
to be of clinical interest. Culture-independent strategies that
characterize the entire bacterial community present in samples
are increasingly being used and are finding new roles in a
diagnostic context (33). These data support the need to view
CF bacterial respiratory infections as polymicrobial and, as
such, more complex than previously considered (10, 15, 27–32,
38, 39). The prevention of bias through the accurate analysis of
samples that represent all bacterial species present has there-
fore become crucial if the roles of these species in disease are
to be understood.
Just as the means of analysis is important, so too is the way
the sample is obtained. By far the most widely used sample in
productive patients is spontaneously expectorated sputum
(SES). SES samples have been shown to have high concor-
dance with bronchoalveolar lavage samples in microbial terms
(17), with the impact of contamination during the process of
expectoration being minimal (31). Further, the use of SES
samples has significant advantages in that they can be collected
with a short notice period and with high frequency.
Where SES samples cannot be obtained, for example, in
nonproductive respiratory conditions such as asthma (6, 14, 22)
or chronic obstructive pulmonary disease (COPD) (4) or in
very young CF patients (8, 24), sputum production may be
induced by the inhalation of nebulized saline (8, 18, 34, 35).
Induced sputum (IS) samples have been shown to be repro-
ducible in terms of their bacterial burden (25). Further, it has
been suggested that the duration of the period of induction
may determine the area from which the sample is drawn, thus
allowing different regions of the airways to be selectively ana-
lyzed. In this way, IS samples might provide topographical data
about the distribution of bacteria within the airways.
Gershman et al. reported that the duration of sputum in-
duction significantly affected the cellular and biochemical com-
position of induced sputum, with the large airways sampled at
the beginning of sputum induction and peripheral airways and
alveoli sampled at later time periods (13). In a later study,
* Corresponding author. Mailing address: Dept. of Respiratory
Medicine, Mater Adult Hospital, Raymond Tce, South Brisbane, Qld.
4101, Australia. Phone: 61731638111. Fax: 61731638519. E-mail: david
.serisier@mater.org.au.
 Published ahead of print on 11 November 2009.
78
 o
n
 O
ctober 21, 2015 by UQ Library
http://jcm.asm.org/
D
ow
nloaded from
 
aliquots taken during 4-min intervals from clinically stable CF
patients were shown to be consistent with this model in terms
of their microbial content (1).
Terminal restriction fragment length polymorphism (T-
RFLP) is a culture-independent molecular profiling technique
that provides an ability to establish bacterial community char-
acteristics, both in terms of the species that are present and
their relative abundance, in a way not afforded in previous
culture-based studies. T-RFLP, when previously applied to CF
SES sample analysis, has indicated the presence of a diverse
array of bacterial species (28, 30, 39). In this study, we used
T-RFLP analysis as a tool to investigate three key topics. First,
do the bacteria detected in SES samples differ from those in IS
samples? Second, is there a trend in the species detected in
sequential IS samples? If so, that might provide insight into
bacterial heterogeneity between different regions of the CF
airways. Third, are more-reproducible species distributions ob-
tained either for SES samples or after a particular induction
period? If so, does this apply to species, such as Pseudomonas
aeruginosa, that are considered to be CF pathogens? The dif-
ferences in the bacterial communities resolved in this study and
the implications for the routine diagnostic microbiological
analysis of CF sputum are discussed.
MATERIALS AND METHODS
Patients. Ten adults with CF, previously diagnosed using standard clinical and
laboratory criteria, were recruited from the adult CF clinic at the Mater Adult
Hospital, a regional specialist CF clinic. All subjects were 16 years of age and
provided written informed consent. The protocol was approved by the local/
regional ethics committee. Subjects were clinically stable, chronic sputum-pro-
ducing outpatients who had not required any supplemental antibiotic therapy in
the 14 days prior to enrollment. Maintenance medications remained stable for
the duration of the study. Baseline characteristics of the study population are
shown in Table 1.
Sample induction and collection. SES and IS samples were obtained from
subjects on three separate days (days 1, 3, and 7). On each of those days,
following mouth-rinsing and expectoration, an SES sample was collected (re-
ferred to here as sample t0). An IS sample was collected following each of four
5-min nebulization periods. These samples have been described here as t5, t10,
t15, and t20, respectively, relative to the SES sample. Sputum induction was
performed after inhalation of 400 g of salbutamol, using 4.5% hypertonic saline
nebulized from a Devilbiss 2000 ultrasonic nebulizer (Devilbiss, Somerset, MA)
according to the standardized protocol recommended by the European Respi-
ratory Society Task Force (26).
All sputum samples were collected in separate sterile containers, placed on ice,
and transported to the microbiology laboratory within 60 min. Specimens were
processed within 3 h, and specimens were kept refrigerated (4°C) in the interim.
The most purulent portion of the specimen was selected, and material was
streaked directly onto horse blood agar (HBA), MacConkey, chocolate with
bacitracin (CHOC-B), Sabouraud agar, Burkholderia cepacia selective agar
(BCEP), and mannitol salt agar. Plates were incubated at 35 to 37°C (HBA and
CHOC-B in CO2 and CHOC-B anaerobically) for at least 48 h (72 h for BCEP)
and examined daily. Samples were then frozen and stored at 80°C (within 60
min) prior to molecular profiling analysis. All diagnostic microbiology was per-
formed at the Department of Respiratory Medicine, Mater Adult Hospital,
Australia, and all molecular profiling analysis was performed at the Molecular
Microbiology Research Laboratory, King’s College London.
DNA extraction, PCR amplification, and T-RFLP profiling. Prior to DNA
extraction, sputum samples were washed three times in 0.9% phosphate-buffered
saline to remove adherent saliva. DNA extraction was performed as previously
described by Rogers et al. (28).
PCR amplification using universal bacterial primers, restriction endonuclease
digestion, and T-RFLP profiling were performed as described by Rogers et al.
(30).
Statistical analysis. The cumulative bacterial taxon richness (the total number
of different bacterial taxa identified after each successive time point) was as-
sessed using taxon-time relationships (TTR). The TTR is used to describe how
the observed taxon richness of a community in a habitat of fixed size increases
with the length of time over which the community is monitored (42, 43). The
TTR is modeled with the power law equation, S cTw, where S is the cumulative
number of observed taxa over time T, c is the intercept, and w is the slope of the
line or temporal scaling exponent (the rate of observation of new bacterial taxa
over the course of the sampling regime), and therefore, increasing values of w
can be taken as greater rates of turnover. Power law regression coefficients of
determination (r2) and significance values were calculated using the Minitab
software program (version 14.20; Minitab, University Park, PA).
Comparisons of community composition were calculated using the Sørenson
index of similarity, which has the equation similarity 2a/(2a b), where a is the
number of cooccurring taxa in two given samples and b is the total number of
taxa occurring in one sample only. Sørenson coefficients were generated using
the PAST (palaeontological statistics program, version 1.21) software program,
available from the University of Oslo website link (http://folk.uio.no/ohammer
/past) run by Øyvind Hammer.
Differences in taxon richness, temporal scaling exponents, and community
composition of samples were performed using one-way analysis-of-variance
(ANOVA) tests. Degrees of freedom, F ratio, and significance (P) values were
calculated using Minitab software. In this way, differences between successive
samples were determined and trends in sample composition within sample sets
were assessed.
RESULTS
Initial experiments confirmed that T-RFLP profiling was
reproducible. Specifically, T-RFLP profiles generated from
DNA extracted from individual sputum samples were found to
be indistinguishable both in terms of repeated extractions (five
aliquots of a single sputum sample) and in terms of PCR
amplification from an individual DNA extraction (five PCRs
TABLE 1. Baseline characteristics of the study populationa
Characteristic Value
Age (yr) ....................................................................................25.7 (4.3)
Female no. (%)..................................................................... 5 (50)
Postbronchodilator FEV1 (liters) .......................................... 1.73 (0.97)
Postbronchodilator FEV1 %..................................................47.6 (19.4)
BMI (kg/m2).............................................................................20.9 (2.2)
Genotype
F508 homozygous ............................................................. 6 (60%)
F508/G551D ...................................................................... 1 (10%)
F508/other.......................................................................... 3 (30%)
RDAb no. (%)
Pseudomonas aeruginosa ..................................................... 9 (90%)
Burkholderia cepacia complex ............................................ 2 (20%)
Staphylococcus aureus ......................................................... 1 (10%)
Medications no. (%)
Azithromycin........................................................................ 9 (90%)
Inhaled corticosteroids ....................................................... 7 (70%)
Inhaled antibiotics............................................................... 8 (80%)
Inhaled DNase..................................................................... 4 (40%)
Oral corticosteroids............................................................. 0
a Data are shown as means (SD) except where percentages are indicated;
n  10. FEV1%, forced expiratory volume in 1 s (FEV1) expressed as a
percentage of the predicted value; BMI, body mass index; RDA, routine
diagnostic microbiology.
b Subjects with chronic pulmonary colonization by the indicated organism
as determined by standard culture techniques; some subjects were colonized
with 	1 organism) . Where detected by RDA, P. aeruginosa, B. cepacia, and
S. aureus colonization was chronic in all patients analyzed here (	8 years of
positive cultures).
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using a single DNA extract as a template) (Fig. 1). Within both
the five replicate extractions and the five replicate amplifica-
tions, the same terminal restriction fragment (T-RF) bands
were detected in each case. In terms of variation in T-RF band
intensity, the standard deviations observed ranged from 3.2 to
5.8 in replicate extractions and from 0.8 to 2.9 in replicate
amplifications (where values are expressed as a percentage of
total signal). As such, this meant that any variation in the
T-RFLP profiles observed subsequently reflected the loss or
gain of a species.
Samples were examined in terms of the number of separate
T-RF bands detected (bacterial taxon richness). Richness mea-
sures ranged from 1 species (patient G, time point 20, sample
day 1) to 10 species (patient E, time point 0, sample day 3),
with a mean value of 5.07 (standard deviation, 
1.9; n  150).
Figure 2 shows plots generated from the temporal variation
in taxon richness for each patient at each time point in com-
FIG. 2. Dynamics of bacterial taxon richness within individual pa-
tients averaged across the three sampling days. T  0 represents a
spontaneously expectorated sputum sample, and samples T  5, T 
10, T  15, and T  20 represent timed induced sputum samples.
Temporal variation in taxon richness (solid circles) in comparison to
the overall mean richness (dashed line) is shown for each patient (a to
j). Also shown are the cumulative taxon richness curves (open circles)
for each patient. Given are the taxon-time power law equation (S 
cTw) and the coefficient of determination (r2). Power regression lines
have been fitted to all cumulative plots. All regression coefficients were
significant (P  0.05). Error bars represent the standard deviations of
the means (n  3).
FIG. 1. Variation in signal intensity, expressed as a percentage of
total signal intensity, of the four T-RF bands resolved in a sputum
sample. Variation is shown in profiles generated from five aliquots of
a single sputum sample (A) or from five PCRs using a single DNA
extract as a template (B).
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parison to the overall mean richness. Figure 2 also shows the
cumulative taxon richness (taxon-time relationship [TTR]) for
each patient at each time point. These data were generated by
averaging data obtained from each patient over the three sam-
pling days. Mean bacterial taxon richness over the 20-min
sampling period for each sampling day was as follows: day 1,
5.12 
 0.89; day 3, 5.12 
 1.22; day 7, 5.06 
 1.32 (n  10),
with the taxon richness values not significantly different across
the three sampling days (ANOVA, F(2,27)  0.02; P  0.984).
The overall mean richness for the combined data was 5.10 

0.270 (n  30). No clear trend was found in terms of temporal
variation in taxon richness compared to the overall mean rich-
ness of samples. In each case, all TTR curves reached, or were
about to reach, an asymptote at the 20-min induction time
point, suggesting further bacterial species were unlikely to be
detected though collection of further samples.
The changes in bacterial community composition at succes-
sive sampling points were then examined. These changes can
be expressed as the similarity (Sørenson index) of each sample
to the original SES sample (here termed the t  0 min sample)
or between successive induced samples. Figure 3 shows the
changes in bacterial community composition observed for in-
dividual patients, averaged across the three sampling days. The
mean total rate of change in composition across the 20-min
sampling period was 31% 
 10% on day 1, 31% 
 9% on day
3, and 34% 
 11% on day 7 (n  10). Sequential change
(comparing a sample to the previous sample) across all pa-
tients was 25% 
 8% on day 1, 34% 
 10% on day 3, and
29% 
 9% on day 7 (n  10). ANOVA for total change over
three sampling days was as follows: F(2,27)  0.34; P  0.712;
and F(2,27)  2.02; P  0.152 for sequential change. Mean total
change ranged from 13% 
 14% (patient D, day 3) to 57% 

8% (patient I, day 7), whereas mean sequential change ranged
from 11%
 12% (patient G, day 1) to 47%
 19% (patient G,
day 3).
Cumulative richness levels for each patient are shown in Fig.
2. Cumulative taxon richness, w, can be expressed as the rate at
which a new species is detected after each 5-min induction
period. The values of w obtained ranged from 0.053 (patient
G) to 0.318 (patient H). The mean temporal scaling exponent
values (the rate of observation of new bacterial taxa over the
course of the sampling regime) for each sampling day over the
20-min sampling period were as follows: day 1, w  0.171 

0.131; day 3, w  0.168 
 0.113; day 7, w  0.187 
 0.144 (n 
10 patients). In addition, the cumulative taxon richness expo-
nents were not significantly different across the three sampling
days (ANOVA, F(2,27)  0.21; P  0.809). This demonstrates
that the rate that new taxa were observed was constant and as
such was not affected by the day of sampling. The overall mean
temporal scaling exponent was 0.175
 0.114 (n 30 patients).
The proportion of the total bacterial taxonomic richness (the
cumulative taxon richness of samples collected at 0-, 5-, 10-,
15-, and 20-min induction periods) that was achieved with the
analysis of increasing numbers of induced sputum samples is
shown in Fig. 4 for all sample sets analyzed. If only a sponta-
neous sputum sample was analyzed, the proportion of total
taxon richness detected was calculated to be 58.7% (
19.8).
Five-, 10-, and 15-min sputum induction periods achieved
77.2% (
18.7), 88.4% (
11.0), and 96.3% (
5.9) of the cu-
mulative taxon richness, respectively, after 20 min.
FIG. 3. Changes in bacterial community composition within indi-
vidual patients (a to j) averaged across the three sampling days. T  0
represents a spontaneously expectorated sputum sample, and samples
T  5, T  10, T  15, and T  20 represent timed induced sputum
samples. Total change (closed circles) represents the similarity (Sø-
renson index) of each sample to the spontaneously expectorated spu-
tum sample (T  0). Sequential change (open circles) represents the
similarity (Sørenson index) of each sample to the preceding sample.
Error bars represent the standard deviations of the means (n  3).
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A total of 81 different T-RF band lengths were resolved in
the profiles generated for samples from the 10 patients ana-
lyzed. These were further clustered into 47 separate T-RF
groups, corresponding to a phylogenetically diverse range of
bacterial species. The membership of these T-RF groups is
shown in Table 2. T-RF bands consistent with P. aeruginosa,
Burkholderia cepacia complex, and Staphylococcus aureus were
detected for 10 patients, two patients, and one patient, respec-
tively. These data matched those generated through routine
diagnostic microbiology (Table 1), except in the case of one
patient, where P. aeruginosa was detected through T-RFLP but
not reported by culture-based microbiology. In addition, T-RF
bands consistent with Stenotrophomonas maltophilia, Alcali-
genes xylosoxidans, and Haemophilus influenzae were detected
in the profiles from one, seven, and two patients, respectively.
T-RF bands consistent with a range of species not normally
associated with respiratory infections in CF but reported pre-
viously through culture-independent analyses were also de-
tected. Particularly prevalent were T-RF bands consistent with
Prevotella spp. (10 patients), Mycobacterium spp. (9 patients),
Clostridium spp. (6 patients), Veillonella spp. (3 patients), and
Streptococcus spp. (3 patients).
The variability of detection of recognized CF respiratory
pathogens in the T-RFLP profiles reflected that of bacterial
taxa generally. Where detected in a particular patient, P.
aeruginosa, B. cepacia, S. aureus, and A. xylosoxidans were
resolved in all SES samples and to various degrees in the IS
sample series—where detected in the SES sample, P. aerugi-
nosa, B. cepacia, S. aureus, and A. xylosoxidans were not de-
tected in 10.2%, 75.0%, 25.0%, and 2.4% of the subsequent IS
samples, respectively. S. maltophilia and H. influenzae were
resolved in some but not all of both SES and IS samples in
patients where detected (S. maltophilia was detected in 66% of
SES and 75% of IS samples in a single patient; H. influenzae
was detected in 50% of SES and 69% of IS samples of two
patients).
Table 3 shows the emergence of T-RF band length groups
after different periods of sputum induction, as determined for
the sample set as a whole. The point in the induction process
at which particular taxa were first detected appeared to be
related to the frequency of their detection in the sample set.
For example, T-RF band length groups 5 and 31 were detected
more often than any others (30 and 25 out of 30 sample sets,
respectively) and were detected in the first sample of the series
in all cases. In contrast, of the eight taxa first detected after 20
min of induction, six were detected in only one induction series
and two were detected in only two induction series.
DISCUSSION
The aim of diagnostic microbiology is to provide data with
which clinicians can make rational and effective therapeutic
decisions. However, certain scenarios can make the reporting
on what species are present in a sample more complicated, for
example, where the material to be sampled is not homoge-
neous. This is compounded when the sample contains a
diverse array of microbes. Both of these issues are likely to
be relevant to the assessment of respiratory infections in the
typical adult CF patient and particularly important given the
key role of diagnostic microbiology in the selection of ap-
propriate therapy (3).
The overall aim of this study was to explore these issues as
applied to respiratory samples from CF patients. To achieve
this, a culture-independent strategy was used to characterize
the bacteria present in both spontaneously produced expecto-
rated CF samples and those generated by successive sputum
induction. The specific aims of this study were to address the
following questions. Did the bacteria detected in SES samples
differ from those in IS samples? Was there any trend in the
species detected in sequential IS samples? Were species dis-
tributions more reproduced in SES samples or after a partic-
ular period of induction?
Before addressing these questions, it is important to exam-
ine the culture-independent analysis systems and what has
been learned through their application. First, through applying
culture-independent techniques, the CF airways have been
shown to be colonized by far more species than previously
thought (10, 27–32, 38, 39). These techniques, as shown again
here, are highly reproducible. However, they also offered
an advantage for this study over earlier culture-based studies in
this area in that it was possible to resolve species whose role in
CF respiratory infections is as yet unknown. Moreover, there is
good evidence that the detection of such a wide range of
species is representative of long-term lower airway coloniza-
tion rather than contamination from the upper airways or oral
cavity (31, 41; also data not shown).
Overall, the data presented here do not indicate a significant
difference in the bacterial composition of SES and IS samples,
regardless of the period for which induction was performed.
However, they do show that in order to obtain a comprehen-
sive view of the bacteria present in the CF lower airways, the
analysis of multiple samples is required. It is only through
the analysis of a number of such samples, in this case five, that
the number of new species resolved with each successive sam-
ple fell away. This is reflected in the finding that analysis of a
single SES sample typically represents only ca. 60% of the
bacterial species found through the analysis of all five samples
FIG. 4. Bacterial taxon richness (left column) and cumulative taxon
richness expressed as percentages (right column) for all patients (n 
10) for all patients and days combined (n  30). T  0 represents a
spontaneously expectorated sputum sample, and samples T  5, T 
10, T  15, and T  20 represent timed induced sputum samples.
Shown are the temporal variation in richness (open circles) and the
cumulative taxon richness (solid circles). Also given are the taxon-time
(S  cTw) and similarity-time (SSOR  cT
b) power law equations and
the coefficient of determination (r2). Power regression lines have been
fitted to all cumulative plots. All regression coefficients were significant
(P  0.05). Error bars represent the standard deviations of the means
(n  30).
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collected in series. This reinforces the need to select with care
the samples to be studied and suggests that sampling in greater
depth may be a more effective strategy. In other diagnostic
contexts, there is evidence that repetition of analysis increases
the accuracy of pathogen detection (19, 36). The ability to
improve species resolution by the analysis of multiple respira-
tory samples was further supported by the data presented here.
A number of previous studies have attempted to determine
the relative merits of SI and SES samples for the analysis of CF
airway infections. Henig et al. (16) reported detection rates as
TABLE 2. Bacterial taxon membership of T-RF band length groups used for analysis of time-dependent species emergence
T-RF band
length group Bacterial taxon membership
a
1 ..................................................................Prevotella sp.
2 ..................................................................Veillonella sp.
3 ..................................................................Clostridium sp.
4 ..................................................................Aquabacterium sp.
5 ..................................................................P. aeruginosa
6 ..................................................................Streptococcus sp., Pasteurellaceae sp.
7 ..................................................................Mycobacterium sp., Actinomyces sp.
8 ..................................................................Mycoplasma sp., Bifidobacterium sp., Streptomyces sp.
9 ..................................................................Clostridium sp., Peptococcus sp., Streptococcus sp.
10 ................................................................B. cenocepacia, Acinetobacter sp., Burkholderia sp., Comamonas sp., Delftia sp., Hemobartonella sp.,
Mycoplasma sp., Nitrosomonas sp., Pseudomonas sp., Stenotrophomonas sp., Thiobacillus sp.,
Variovorax sp., Wautersia sp.
11 ................................................................Acinetobacter sp., Alteromonas sp., Burkholderia sp., Comamonas sp., Nitrosomonas sp., Pandoraea
sp., Pseudomonas sp., Ralstonia sp., Salinimonas sp., Simonsiella sp.
12 ................................................................Actinomyces sp., Burkholderia sp., Chromohalobacter sp., Halomonas sp., Kingella sp., Nitrosomonas
sp., Pseudomonas sp., Psychrobacter sp., Ralstonia sp., Simonsiella sp., Stenotrophomonas sp.
13 ................................................................Actinomyces sp., Bifidobacterium sp., Halomonas sp., Pseudoalteromonas sp., Pseudomonas sp.,
Shewanella sp., Spirochaeta sp., Stenotrophomonas sp., Thauera sp.
14 ................................................................Actinomyces sp., Cardiobacterium sp., Clostridium sp., Legionella sp., Neisseria sp., Paracoccus sp.,
Proteus sp., Shewanella sp., Simonsiella sp., Stenotrophomonas sp., Xanthomonas sp.
15 ................................................................Stenotrophomonas sp., Fusobacterium sp., Eikenella sp., Enterococcus sp.
16 ................................................................Enterococcus sp., Clostridium sp.
17 ................................................................Mycoplasma sp., Clostridium sp.
18 ................................................................S. aureus, Clostridium sp., Bacillus sp.
19 ................................................................Bacillus sp.
20 ................................................................Acidobacteria sp.
21 ................................................................Uncharacterized
22 ................................................................Uncharacterized
23 ................................................................H. influenzae, Mycobacterium sp., Haemophilus sp.
24 ................................................................Actinobacteria sp., Aeromonadaceae sp., Agromyces sp., Alteromonas sp., Amycolatopsis sp.,
Bifidobacterium sp., Burkholderia sp., Cellulomonas sp., Corynebacterium sp., Curtobacterium sp.,
Enterobacter sp., Gordona sp., Haemophilus sp., Histophilus sp.
25 ................................................................Uncharacterized
26 ................................................................Uncharacterized
27 ................................................................Nitrobacter sp.
28 ................................................................Nocardia sp., Mycobacterium sp.
29 ................................................................Haemophilus sp., Aeromonas sp.
30 ................................................................Alcaligenes sp., Streptomyces sp.
31 ................................................................Alcaligenes xylosoxidans, Acidovorax sp., Alcalivorax sp., Bordetella sp., Bacillus sp., Brackiella sp.,
Burkholderia sp., Cardiobacterium sp., Cardococcus sp., Catonella sp., Collimonas sp.,
Comamonas sp., Erwinia sp., Gallionella sp., Halomonas sp.
32 ................................................................Aeromonas sp., Bordetella sp., Eikenella sp., Kingella sp., Moritella sp., Neisseria sp., Oligella sp.,
Pseudomonas sp., Ralstonia sp., Shewanella sp., Simonsiella sp., Streptococcus sp.
33 ................................................................Capnocytophaga sp., Dialister sp., Enterococcus sp., Peptococcus sp., Streptococcus sp., Veillonella sp.
34 ................................................................Dialister sp., Enterococcus sp., Peptococcus sp., Selenomonas sp.
35 ................................................................Capnocytophaga sp., Veillonella sp.
36 ................................................................Brevibacterium sp., Lactobacillus sp.
37 ................................................................Weissella sp., Lactobacillus sp.
38 ................................................................Prevotella sp.
39 ................................................................Uncharacterized
40 ................................................................Uncharacterized
41 ................................................................Alcaligenes sp.
42 ................................................................Uncharacterized
43 ................................................................Uncharacterized
44 ................................................................Uncharacterized
45 ................................................................Uncharacterized
46 ................................................................Uncharacterized
47 ................................................................Uncharacterized
a Boldface indicates recognized pathogens in CF lung infections.
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determined through culture-based analysis of P. aeruginosa, B.
cepacia complex, S. maltophilia, A. xylosoxidans, H. influenzae,
and S. aureus of 79% for SI compared with 76% for SES,
suggesting that any difference was not significant (16). Using
comparable methods, Sagel et al. reported that the same
pathogens were isolated in similar colony counts from both the
induced and expectorated sputum samples from productive CF
patients (35). However, there is evidence that colonizing bac-
teria are not distributed evenly throughout the CF lower air-
ways (7, 23), and therefore, an ability to determine the pres-
ence at different points through a simple, noninvasive sampling
method would be of great benefit. The findings of Gershman et
al. and Aitken et al. lent support to the suggestion that sputum
induction could be used to differentially sample regions of the
airways by being performed for different periods time (1, 13).
However, while the data presented here are consistent with the
findings of Henig et al. (16) and Sagel et al. (35), a relationship
between the induction period and the sample composition of
the type reported by Gershman et al. and to a degree Aitken et
al. (1) was not identified. It is likely that this arises from a
number of key differences between the studies, most impor-
tantly the fact that the Gershman study was performed with
nonproductive patients. In such circumstances, it is not unrea-
sonable to suggest, as they did, that the airway secretions that
result from induction will be expectorated according to their
distance from the upper airways, with materials from deeper in
the airways being expectorated last. However, in our study,
patients were already productive. As such, material that was
expectorated first in the induction series may have originated
from the lower airways and have already traveled some dis-
tance up the airways before sample collection began. In this
way, the link between heterogeneous distribution of airway
bacteria and induction time may have been disrupted.
T-RFLP data generated from individual patients over the
three sampling days were examined to determine whether a
particular sample type or sputum induction time provided
more-consistent samples. The three sampling days fell over a
seven-day period during which the patient was stable. This
variation was not significantly higher for any particular time
point or sample type, however. The degree to which such
variation reflects underlying changes in airway disease is un-
determined. However, these data underline the importance of
a sampling strategy that involves the collection of multiple
samples at given time points. The sampling days (days 1, 3, and
7) were chosen to provide sufficient time for any effects of the
sputum induction process to pass yet working on the assump-
tion that there would be no marked changes in underlying
respiratory microbiology. The data suggested that despite the
high levels of reproducibility demonstrated for the techniques
employed, the profiles generated from samples taken after
particular induction periods varied to an extent across sam-
pling days. However, this variation was not significantly higher
for any particular time point or sample type. The degree to
which such variation reflects underlying changes in airway dis-
ease is yet to be determined.
It is also important to explore the potential reasons why the
variability in bacterial species detected was observed. The
physical conditions that bacterial cells encounter will vary
along the course of the respiratory tract. Arguably, the most
significant of these varying parameters is oxygen tension.
Chronic bacterial infection in the lower airways is known to
reduce oxygen tension (2), and P. aeruginosa is known to grow
anaerobically in the CF lung (45). In addition, a number of
anaerobic species have been reported in CF lung infections
(41, 44). It may be the case, therefore, that different bacterial
species are distributed unevenly through the respiratory tract
according to their ability to adapt to and grow under these
conditions. However, the data presented here regarding the
first detection of bacterial species suggest that the relationship
TABLE 3. Emergence of bacterial T-RF band length groupsa
T-RF band
length group
No. of occurrences for
period of sputum
induction (min)
No. of
samples
Mean % (SD) of
profile signal
0 5 10 15 20
1 17 3 4 3 27 5.5 (7.6)
2 1 1 28.4
3 1 3 2.7 (0.3)
4 1 1 0.62
5 30 138 49.0 (25.0)
6 1 1 3.29
7 1 1 1 7 10.9 (18.1)
8 1 1 3 2.5 (0.2)
9 3 1 1 11 2.2 (1.7)
10 3 11 34.5 (17.8)
11 3 1 1 1 16 3.1 (3.1)
12 4 11 5.1 (7.91)
13 2 1 3 1.3 (0.9)
14 2 1 14 40.7 (24.8)
15 1 2 10 3.2 (3.0)
16 1 1 0.8
17 2 1 7 3.4 (3.3)
18 4 1 3 1 19 2.1 (1.2)
19 1 1 1 1 10 1.0 (0.4)
20 1 1.9
21 1 2 5 2.0 (2.7)
22 2 2 12 4.6 (3.0)
23 4 3 2 1 28 4.5 (3.2)
24 5 2 1 1 25 6.2 (5.4)
25 2 2 0.9 (0.2)
26 3 4 1 12 2.6 (1.5)
27 2 3 14 3.5 (3.5)
28 6 1 1 2 1 21 1.5 (1.1)
29 1 4 1.8 (1.9)
30 1 1 26.6
31 25 130 34.8 (15.6)
32 2 1 14 26.0 (6.3)
33 1 1 4 15.9 (12.7)
34 5 13 20.8 (11.4)
35 1 3 5.2 (2.7)
36 1 2 4.5 (1.0)
37 1 1 2 6.1 (1.0)
38 2 3 2 1 1 17 5.9 (5.2)
39 3 11 6.1 (3.2)
40 1 1 1 4 2.3 (1.0)
41 1 1 2 3.3 (1.8)
42 2 1 2 1 2 16 2.9 (3.0)
43 2 1 10 4.2 (2.8)
44 2 2 0.7 (0.4)
45 3 1 13 8.2 (6.6)
46 5 1 1 29 6.0 (5.6)
47 1 1 1 7 8.6 (9.2)
a Values represent the number of instances in which each T-RF band length
group was first detected after a given period of induction in each of the 30 sets
of samples analyzed (10 patients, sampled on three separate days). The mean
percentage of the total profile signal represented by each T-RF band length
group and the standard deviation are shown.
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between the period of sputum induction and the detection of
particular groups of bacteria may not be related to the growth
traits of particular species alone. Instead, other factors, most
notably the prevalence of a species within the airways, signif-
icantly influence when a species is first detected.
As discussed above, and as might be anticipated, where
species have a high mean percentage of total profile signal,
they tend to be detected in the initial SES sample. However,
exceptions to this were found. For example, T-RF band 2,
consistent with Veillonella spp., was resolved as ca. 25% of the
final (t20) profile (patient 9) yet was not present in any other
sample from this patient. This does not mean that all anaer-
obes are heterogeneously distributed in the airways, however.
For example, in over 60% of instances where Prevotella species
were detected, they were detected in the original SES sample.
Although the degree to which secretions from different regions
of the airways contribute to SES samples is not known, some
studies have considered the origin of SES samples. Mussaffi et
al., for example, believed that SES samples were pooled secre-
tions derived from the lower airways (24). Further, attempts to
determine whether the induction period influences the area of
the airways sampled is hampered by a lack of data regarding
the spatial distribution of species within the lungs, suggesting
further investigation into the differential location of particular
species would be of great benefit. Aitken et al. attempted to
determine whether there were differences in the bacterial load
of particular species in samples obtained after various periods
of induction (1). For example, they reported that P. aeruginosa
and S. aureus decreased over the 20-min time period. However,
the lack of an indication that sequential samples represent
different regions of the airways meant that such investigation
was unlikely to provide further insight into the questions of
bacterial distribution addressed in this study.
SI samples are both safe and noninvasive (5, 21) and as such
have a proven potential for analysis of nonproductive airway
conditions, such as asthma, COPD, and nonproductive, pedi-
atric CF remains (37). However, the data presented in this
study suggest that single SI samples do not provide a clear
advantage over SES samples in the study of productive respi-
ratory infections, such as those associated with CF.
Culture-independent analysis has been demonstrated to be
valuable in the detection of bacterial pathogens in culture-
negative samples (40). Further, its ability to provide a nonse-
lective characterization of bacterial species in clinical samples
means that its use in diagnostics will expand. However, the
quality of the data generated using such strategies relies on a
number of considerations regarding the samples analyzed. Pre-
vious studies have sought to determine the reproducibility of
certain sample types for culture-based diagnostic microbiology
(12). However, these may need to be reassessed in the context
of molecular analysis.
The data presented in this study underline the importance of
basing analysis of bacterial presence in the lower airways on
more than one sample. Data presented indicate that the reli-
ance on a single SES or IS sample will resolve only a portion of
the bacteria present. This has important implications, both for
the detection of species recognized to be clinically important
CF pathogens and in the identification of species whose role in
CF lung infections is not yet known. The analysis of more than
one sample may seem particularly challenging currently in a
diagnostic context. However, if we are to address the issues
raised here appropriately, this may be necessary, assisted by
applying increasingly automated processes. It is clear, however,
that as analytical techniques become more sophisticated, the
quality of the data that they provide is not undermined (9, 11,
20). This applies to CF respiratory samples and may be rele-
vant for a wider range of infections where sample type and
frequency could have a diagnostic bearing.
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